Antimicrobial

Global Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology 2021-2025, with 30+ Company Profiles - ResearchAndMarkets.com

Retrieved on: 
星期三, 五月 12, 2021

b'The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization - 2021 to 2025" report has been added to ResearchAndMarkets.com\'s offering.\nDiagnostics are leading the charge in reducing the threat posed by antimicrobial resistance.

Key Points: 
  • b'The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization - 2021 to 2025" report has been added to ResearchAndMarkets.com\'s offering.\nDiagnostics are leading the charge in reducing the threat posed by antimicrobial resistance.
  • Will these technologies solve the problem before new antibiotics come along?
  • New diagnostic technologies, beyond gene sequencing, are under development to capture this growing market.\nThis report provides a plain language understanding of the different ways pathogens, and infections can be diagnosed.
  • The report has identified the 6 Key Large Pathogen Opportunities in this space and developed market forecasts.

Germ Protection Is IN the Bag! Spread Love, Not Germs

Retrieved on: 
星期三, 五月 5, 2021

b'PHILADELPHIA, May 5, 2021 /PRNewswire/ --ThePureBag company launched in 2018 (pre-Covid) withingeniously designed antimicrobial bags + accessories for adventuring lifestyles.

Key Points: 
  • b'PHILADELPHIA, May 5, 2021 /PRNewswire/ --ThePureBag company launched in 2018 (pre-Covid) withingeniously designed antimicrobial bags + accessories for adventuring lifestyles.
  • Today, ThePureBag products take mainstage in inhibiting germs and germ growth - including bacteria, fungus, mold and mildew.
  • Looking for a gift to show you care or for that hard-to-buy-for friend?
  • The healthcare-grade antimicrobial fabric inhibits germs including bacteria, fungus, mold and mildew.

New Antimicrobial Coatings for Printed Products Increase Safety in the Workplace and Marketplace

Retrieved on: 
星期二, 五月 4, 2021

The finished product is indistinguishable from those without, and it costs only pennies to add.

Key Points: 
  • The finished product is indistinguishable from those without, and it costs only pennies to add.
  • Each printed piece can carry the optional CLEANERPRINT symbol for additional consumer awareness.
  • "\nWestamerica\'s Antimicrobial Protection is a complete surface coating applied directly to the paper during the printing process.
  • "\nFor just pennies, the treatment delivers a cost-effective and permanent antimicrobial product protection of your printed materials.

DEINOVE, ESPCI Paris and INRAE awarded grant following the call for proposals of the French “Antibiotic resistance” Priority Research Program

Retrieved on: 
星期四, 四月 29, 2021

The evaluations reached the same conclusion: the microfluidic technology developed by DEINOVE is considered by the scientific and industrial community as a major asset for the screening and identification of new therapeutic solutions from bacterial biodiversity.\nAntibiotic resistance has become a major public health emergency that is now mobilizing the entire international community5, and of course France.

Key Points: 
  • The evaluations reached the same conclusion: the microfluidic technology developed by DEINOVE is considered by the scientific and industrial community as a major asset for the screening and identification of new therapeutic solutions from bacterial biodiversity.\nAntibiotic resistance has become a major public health emergency that is now mobilizing the entire international community5, and of course France.
  • By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance.
  • Today, DEINOVE is conducting several development programs, of which its first antibiotic candidate is currently evaluated in a Phase II clinical trial in severe Clostridioides difficile infections, one of the world\xe2\x80\x99s first emergencies.
  • It aims to support \xe2\x80\x9cvery ambitious, structuring, long-term (3 to 6 years) research projects favoring interdisciplinarity and contributing to the emergence of synergies between different types of research (fundamental, environmental, clinical, translational), with the goal of stimulating and supporting the emergence of diagnostic, preventive and therapeutic innovations, and ultimately leading to a better use of antibiotics\xe2\x80\x9d.\n'

Soft-Tex International, Inc. Expands Antimicrobial Product Protection Offerings in Partnership with Microban International

Retrieved on: 
星期四, 四月 29, 2021

b'WATERFORD, N.Y., April 29, 2021 /PRNewswire/ --Soft-Tex International Inc., a leading innovator of sleep and home comfort products, today announced an expanded suite of antimicrobial treated bedding offerings through an expanded partnership with Microban International, the global leader in antimicrobial solutions.

Key Points: 
  • b'WATERFORD, N.Y., April 29, 2021 /PRNewswire/ --Soft-Tex International Inc., a leading innovator of sleep and home comfort products, today announced an expanded suite of antimicrobial treated bedding offerings through an expanded partnership with Microban International, the global leader in antimicrobial solutions.
  • The unique patented technologies contain ultra-fine silver crystals that release silver ions at a controlled rate only when the conditions for bacterial growth exist.
  • Microban drives innovation by combining science and creative solutions that enhance high-quality consumer, textile, industrial and medical products around the world.
  • Today the Microban brand and technologies are featured on thousands of products worldwide.

New PhRMA Report Shows Nearly 90 Medicines in Development to Fight Drug-Resistant Infections, but Future Pipeline Remains Challenging

Retrieved on: 
星期四, 四月 29, 2021

Today, this progress is being threatened by a health crisis on the rise: antimicrobial resistance (AMR).

Key Points: 
  • Today, this progress is being threatened by a health crisis on the rise: antimicrobial resistance (AMR).
  • Developing new antimicrobial medicines can take anywhere from 10-20.5 years and $568-$700 million to develop a single new medicine.
  • In fact, among investigational medicines in preclinical development for existing classes of antibiotics just one in 15 will ultimately be approved and reach patients.
  • Those new treatments could be the ones we need to address the next pandemic, or the next superbug.

SiShield's Antimicrobial Disinfectant and Surface Coating (SiS 200D RTU) Has Been Added to the Environmental Protection Agency's List N: Disinfectants for Use Against SARS-CoV-2 (COVID-19)

Retrieved on: 
星期三, 四月 28, 2021

When tested at an GLP accredited laboratory, SiS 200D RTU was found to eliminate99.99% ofHuman Coronavirus Strain 229 E, ATCC VR-740 on hard, nonporous environmental surfaces, at a contact time of 10 minutes.

Key Points: 
  • When tested at an GLP accredited laboratory, SiS 200D RTU was found to eliminate99.99% ofHuman Coronavirus Strain 229 E, ATCC VR-740 on hard, nonporous environmental surfaces, at a contact time of 10 minutes.
  • It is the world's firstpatented water-based, durable, non-toxic, relatively safe, and non-flammable, non-leaching and non-migrating (after it is bound), odorless and colorless disinfectant and microbiostatic agent.
  • SiShield's mission is to be the leading supplier of antimicrobial products through innovation, vast experience, and dedication to meeting its customer's antimicrobial needs.
  • For more information on the patented technology, please visit www.sishield.com .\nWe are actively monitoring [email protected] for press inquiries.\n"

ContraFect Invited to Participate in the Cystic Fibrosis Target Product Profile Virtual Symposium

Retrieved on: 
星期一, 四月 26, 2021

The symposium has been established by the CF Syndicate in Antimicrobial Resistance (AMR) and is supported by the Cystic Fibrosis Trust and The Medicines Discovery Catapult, both United Kingdom based organizations fostering cutting edge therapeutic research.

Key Points: 
  • The symposium has been established by the CF Syndicate in Antimicrobial Resistance (AMR) and is supported by the Cystic Fibrosis Trust and The Medicines Discovery Catapult, both United Kingdom based organizations fostering cutting edge therapeutic research.
  • An estimated 700,000 deaths worldwide each year are attributed to antimicrobial-resistant infections.
  • We intend to address life threatening infections using our therapeutic product candidates from our platform of DLAs, which include lysins and amurin peptides.
  • Important factors that could cause actual results to differ include, among others, our ability to develop treatments for drug-resistant infectious diseases.

OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections

Retrieved on: 
星期一, 四月 19, 2021

\xe2\x80\x9cThe quick spread of antimicrobial resistant superbugs across healthcare systems is the silent pandemic hidden underneath the current COVID-19 pandemic.

Key Points: 
  • \xe2\x80\x9cThe quick spread of antimicrobial resistant superbugs across healthcare systems is the silent pandemic hidden underneath the current COVID-19 pandemic.
  • Together, these products can help to rapidly identify and locate antibiotic resistance threats in healthcare institutions and networks.
  • Victory Derbyshire\xc2\xa0said,\xc2\xa0\xe2\x80\x9cUnder Governor Cuomo\'s leadership New York State\xc2\xa0continues to lead the nation in addressing the threat of antimicrobial resistance.
  • The Center serves a vital role in the\xc2\xa0New York State Department\xc2\xa0of Health\xe2\x80\x99s efforts to protect and promote the health of New York\xe2\x80\x99s citizens.

Nearly half a million dollars to fund a research chair to ensure food safety and quality

Retrieved on: 
星期四, 四月 22, 2021

b'MONTRAL and LAVAL, QC, April 22, 2021 /CNW Telbec/ - What are the antimicrobial effects of stabilized natural products to ensure food safety and quality?

Key Points: 
  • b'MONTRAL and LAVAL, QC, April 22, 2021 /CNW Telbec/ - What are the antimicrobial effects of stabilized natural products to ensure food safety and quality?
  • This funding will make it possible to develop different stabilization methods, such as food coating via immobilization in edible polymers.
  • "\nThe project is also evaluating the possible interactions between food composition, processing and storage conditions, and the resulting antimicrobial activity.
  • I am already looking forward to the advances that the work of the chair in food safety and quality will allow.